|Novel Cancer Therapeutics Summit|
Oncology Partnering & Deal-Making
The field of Cancer Immunotherapy is of continuously escalating significance, as well as scientifically, economically and socially important. The Cancer Immunotherapy Conference on October 19-20, 2017 in Boston, MA allows scientists, clinicians, and R&D experts to meet together and discuss the latest therapeutic, preventive and diagnostic developments in the field.
The immune system plays a central role not only in fighting infections, but also in many other diseases and medical conditions including cancer. The study of the immune system has lead to significant findings in many fields of medicine and biology and has resulted in the discovery of novel and unique substances and reagents that are now widely used for diagnosis, evaluation and therapy of different malignant diseases. The development of prophylactic and therapeutic vaccines, as well as innovative combinatorial immunotherapeutic approaches for patients with cancer has substantially decreased mortality and morbidity and improved the life, life expectancy, and the well being of the millions of patients with malignant diseases.
We hope to see you there!
The 2017 Advisory Committee
Amber Kempf at 626-256-6405 x110 or amber.kempf [at] gtcbio.com
For more information on Media Relations, please contact:
Jennifer Chu at 626-256-6405 x105 or jennifer.chu [at] gtcbio.com